GlassScriptPhysician profile
David L Kemp
NPI 1366474918
$970.54
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $670 · 2020: $144 · 2021: $64.36 · 2022: $91.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $230.71 | 2019-2021 | |
| Amgen INC. | $147.93 | 2019-2020 | |
| Abbott Laboratories | $109.76 | 2020-2022 | |
| Pfizer INC. | $96.45 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $78.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $47.56 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.46 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $42.79 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $42.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.44 | 2019 | |
| Biotronik INC. | $13.74 | 2021 | |
| Portola Pharmaceuticals, LLC | $11.54 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.